Target intelligence / Profile preview

Primary amine oxidase

Molecular classification
Enzyme, Amine oxidase, Copper amine oxidase (in certain bacteria)
01

Overview

Primary amine oxidase, also referred to as phenylethylamine oxidase or copper amine oxidase in certain bacterial species, is an enzyme that catalyzes the oxidative deamination of primary aromatic amines like phenylethylamine, producing the corresponding aldehyde, ammonia, and hydrogen peroxide. In humans, analogous activity is performed by monoamine oxidase A and monoamine oxidase B, which play crucial roles in neurotransmitter catabolism and are therapeutic targets in neurological and psychiatric disorders. In microorganisms such as Arthrobacter globiformis, this enzyme is copper-dependent and uses topaquinone as a cofactor.

Other names
2-phenylethylamine oxidasecopper amine oxidasetyramine oxidasetynA (bacterial)monoamine oxidase (if referring broadly in mammals)MAO-AMAO-Bsemicarbazide-sensitive amine oxidase (SSAOs, but these have broader substrate scopes)
02

Mechanism of action

Inhibition of amine oxidase enzymatic activity, resulting in decreased breakdown of amines (such as phenylethylamine) and increased synaptic concentrations

03

Biological functions

Oxidative deamination of primary amines (including phenylethylamine)Amine catabolismRegulation of amine neurotransmitter levels
04

Disease associations

Neurodegenerative disease (by analogy with MAO-A/B)Psychiatric disorder (by analogy with MAO-A/B)Peripheral inflammation (by analogy with SSAOs, if broader amine oxidases are considered)
05

Safety considerations

Hypertensive crisis (with nonselective MAO inhibition and dietary amines)Serotonin syndrome (with MAO inhibition)Potential for off-target effects due to broad amine substrate specificity
06

Interacting drugs

Monoamine oxidase inhibitors (e.g., phenelzine, tranylcypromine, selegiline; these target MAO-A and MAO-B)

1 more in the full profile.

07

Biomarkers

Changes in monoamine or amine metabolite levels (e.g., phenylacetic acid in urine as PEA metabolite)Enzyme activity assays (for amine oxidase)

Beyond the preview

Go deeper on Primary amine oxidase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primary amine oxidase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call